Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ibuprofen + narcotic
- Development stage
- Unknown
- Lead developer
- Johnson & Johnson
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Motrin + narcotic is a multimodal analgesic regimen developed by Cape Fear Valley Health System for the management of postoperative pain in adult outpatients. This intervention is not a single fixed-dose combination but a clinical protocol pairing 800 mg of ibuprofen (Motrin), a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes (COX-1 and COX-2), with one of several opioid analgesics, including oxycodone/acetaminophen, hydrocodone/acetaminophen, hydromorphone, or tramadol. The regimen is currently being evaluated in a Phase 4 clinical trial (NCT06495632) to compare the efficacy and feasibility of a fixed-schedule administration versus an as-needed (PRN) approach for moderate-to-severe pain following same-day surgery.
- Brand names
- Motrin
- Other names
- Motrin + narcoticMotrin and narcoticScheduled or As Needed Regimen? a Pilot Feasibility Study on Multimodal Pain Control and Post-Operative Pain
02
Targets
MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on ibuprofen + narcotic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ibuprofen + narcotic.